HIGH GRADE SEROUS FALLOPIAN TUBE CARCINOMA
Clinical trials for HIGH GRADE SEROUS FALLOPIAN TUBE CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HIGH GRADE SEROUS FALLOPIAN TUBE CARCINOMA trials appear
Sign up with your email to follow new studies for HIGH GRADE SEROUS FALLOPIAN TUBE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New mRNA vaccine aims to stop ovarian Cancer's return
Disease control Recruiting nowThis early-stage trial tests a new mRNA cancer vaccine called CryptiVax-1001 in 50 women with advanced ovarian cancer. The vaccine is designed to train the immune system to recognize and attack cancer cells, potentially delaying or preventing the cancer from coming back. The main…
Matched conditions: HIGH GRADE SEROUS FALLOPIAN TUBE CARCINOMA
Phase: PHASE1 • Sponsor: Epitopea Ltd • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New combo therapy targets Platinum-Resistant ovarian cancer
Disease control Recruiting nowThis early-phase study tests a new drug called azenosertib (ZN-c3) combined with standard chemotherapy or bevacizumab in people with ovarian, peritoneal, or fallopian tube cancer that has stopped responding to platinum-based treatment. About 172 participants will receive differen…
Matched conditions: HIGH GRADE SEROUS FALLOPIAN TUBE CARCINOMA
Phase: PHASE1 • Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New pill shows promise against tough cancers – early trial underway
Disease control Recruiting nowThis study tests an experimental drug called ART0380, taken as a pill, in people with advanced or metastatic solid tumors (cancers that have spread). The drug targets a protein that helps cancer cells repair their DNA. Researchers want to find the safest dose when given alone or …
Matched conditions: HIGH GRADE SEROUS FALLOPIAN TUBE CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Artios Pharma Ltd • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC